Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 9, 2004, Pages 1676-1681

  Reddy, Srinivasa T ^a   Nguyen, Julie T ^a   Grijalva, Victor ^a   Hough, Greg ^a   Hama, Susan ^a   Navab, Mohamad ^a   Fogelman, Alan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Lipoprotein oxidation; MKP 1; Phosphatase inhibitor

Indexed keywords

APOLIPOPROTEIN E; CD68 ANTIGEN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERY ENDOTHELIUM; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LIPID OXIDATION; LIVER; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

AGE FACTORS; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AORTIC DISEASES; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CELL CYCLE PROTEINS; DIET, ATHEROGENIC; DIMYRISTOYLPHOSPHATIDYLCHOLINE; ENZYME INDUCTION; IMMEDIATE-EARLY PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MAP KINASE KINASE 4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MODELS, ANIMAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, LDL; RNA, MESSENGER; SEX FACTORS; VANADATES;

EID: 4444342219     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000138342.94314.64     Document Type: Article

References (20)

1. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms, oxidation, inflammation and genetics. Circulation. 1995;91:2488-2496.
2. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM. The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol. 1996;16:831-842.
3. Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM. Oxidized lipids as mediators of coronary heart disease. Curr Opin Lipidol. 2002;13:363-372.
4. Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy ST, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, and Fogelman AM. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2001;21:481-488.
5. Reddy ST, Grijalva V, Ng C, Hassan K, Hama S, Mottahedeh R, Wadleigh DJ, Navab M, Fogelman AM. Identification of genes induced by oxidized phospholipids in human aortic endothelial cells. Vasc Pharmacol. 2002;38:211-218.
6. Guan KL, Broyles SS, and Dixon JE. Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature. 1991;350:359-362.
7. Keyse SM, and Emslie EA. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature. 1992;359:644-647.
8. Reddy ST, Grijalva V, Hama S, Hassan K, Mottahedeh R, Navab M, and Fogelman AM. Induced map kinase phosphatase-1 activity is necessary for the accumulation of monocyte chemotactic activity in Ox-PAPC treated human aortic endothelial cells. J Biol Chem. 2001;76:17030-17035.
9. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL, Lusis AJ. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb. 1994;14:1480-1497.
10. Reddy S, Hama S, Grijalva V, Hassan K, Mottahedeh R, Hough G, Wadleigh DJ, Navab M, Fogelman AM. Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells. J Biol Chem. 2001;276:17030-17035.
11. Navab M, Hama S, Hough G, Fogelman AM. Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice. Circulation. 2003;108:1735-1739.
12. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res. 2004;64:1757-1764.
13. Pervin S, Singh R, Freije WA, Chaudhuri G. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. Cancer Res. 2003;63:8853-8860.
14. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Caron M, Atfi A, Cherqui G, Capeau J. Insulin-mediated cell proliferation and survival involve inhibition of c-Jun N-terminal kinases through a phosphatidylinositol 3-kinase- and mitogen-activated protein kinase phosphatase-1-dependent pathway. Endocrinology. 2000;141:922-931.
15. Grimshaw MJ, Balkwill FR. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation-a potential mechanism. Eur J Immunol. 2001;31:480-489.
16. Magi-Galluzzi C, Loda M. Molecular events in the early phases of prostate carcinogenesis. Eur Urol. 1996;30:167-176.
17. Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA, Bravo R. Disruption of the ERP/MKP-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene. 1996;13:925-931.
18. Meyerovitch J, Waner T, Sack J, Kopolovic J, Shemer J. Attempt to prevent the development of diabetes in non-obese diabetic mice by oral vanadate administration. Isr Med Assoc J. 2000;2:211-214.
19. Gordon JA. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 1991;201:477-482.
20. Hadari YR, Geiger B, Nadiv O, Sabanay I, Roberts CT Jr, LeRoith D, Zick Y. Hepatic tyrosine-phosphorylated proteins identified and localized following in vivo inhibition of protein tyrosine phosphatases: effects of H2O2 and vanadate administration into rat livers. Mol Cell Endocrinol. 1993;97:9-17.